Primary immunodeficiencies (PIDs) are a heterogeneous group of inherited disorders, frequently caused by loss-of-function and less commonly by gainof-function mutations, which can result in susceptibility to a broad or a very narrow range of infections but also in inflammatory, allergic or malignant diseases. Owing to the wide range in clinical manifestations and variability in penetrance and expressivity, there is an urgent need to better understand the underlying molecular, cellular and immunological phenotypes in PID patients in order to improve clinical diagnosis and management. Here we have compiled a manually curated collection of public transcriptome datasets mainly obtained from human whole blood, peripheral blood mononuclear cells (PBMCs) or fibroblasts of patients with PIDs and of control subjects for subsequent meta-analysis, query and interpretation. A total of nineteen (19) datasets derived from studies of PID patients were identified and retrieved from the NCBI Gene Expression Omnibus (GEO) database and loaded in GXB, a custom web application designed for interactive query and visualization of integrated large-scale data. The dataset collection includes samples from well characterized PID patients that were stimulated ex vivo under a variety of conditions to assess the molecular consequences of the underlying, naturally occurring gene defects on a genome-wide scale. Multiple sample groupings and rank lists were generated to facilitate comparisons of the transcriptional responses between different PID patients and control subjects. The GXB tool enables browsing of a single transcript across studies, thereby providing new perspectives on the role of a given molecule across biological systems and PID patients. This dataset collection is available at: http://pid.gxbsidra.org/dm3/geneBrowser/list.
MAIN BODY Introduction
Primary immunodeficiencies (PIDs) are a heterogeneous group of inherited disorders, most often caused by loss-of-function mutations and less commonly by gain-of-function mutations, affecting components of the innate and/or adaptive immune system [1] [2] [3] . These inborn errors of immunity can result in profoundly increased susceptibility to a broad or a very narrow range of infections but also autoimmune disorders, allergies and malignancies [1, [4] [5] [6] . The spectrum of clinical manifestations of PIDs is very broad and largely dependent upon the affected gene(s) and the degree to which normal gene function is lost or altered. In addition, a variety of other factors such as germline or somatic mosaicism, modifier genes and environmental factors can play an important role in the clinical penetrance and expressivity of a given disease phenotype [3, 7, 8] . To date, mutations in more than 300 genes have been identified to cause PIDs, which are classified into major groups reflecting the diverse immunological phenotypes [5, 9] . Nonetheless, PIDs often go unrecognized or are not properly diagnosed [10] . However, with the recent developments and rapidly declining costs of next-generation sequencing technologies and other high-throughput methods, it is expected that many more as yet unknown disease-related genetic variants will be discovered in the near future [7] .
A considerable challenge for identifying causal genetic variants-which is critical for the diagnosis and clinical management of PID patients-lies in the vast heterogeneity of the underlying immunological phenotypes and clinical manifestations on the one hand and in the degree of human genetic variation between individuals on the other hand. Despite considerable advances in recent years, specific gene functions in humans, their roles and regulation in biological processes, and essentiality of the redundancy in a function of a particular gene for protective immunity of the human host remains poorly understood [6] . In many cases, the use of forward and reverse genetics in mice or other model organisms has provided insufficient insights into the pathophysiology of PIDs due to interspecies differences and the fact that inbreeding has let to various deficiencies in laboratory animals, rendering them susceptible to a broad range of infections that often poorly recapitulates the clinical phenotypes in humans [11] . On the other hand, studying naturally occurring genetic defects in humans is much more challenging given the difficulty of obtaining biological samples, ethical implications and potential risks that go along with it. An additional challenge is the low frequency of most null alleles. Although PIDs are not necessarily rare when considered collectively, the small number of individuals that suffer from a specific deficiency usually does not permit classic case-control or family-based genetic association studies. Indeed, a considerable proportion of monogenic etiologies of PIDs were initially reported in single patients [12] . The ability to identify single-gene inborn errors in PID patients requires validation of the disease-causing variant by in-depth mechanistic studies demonstrating the structural and functional consequences of the mutations using blood or other accessible biological samples such as fibroblasts from skin biopsies [12] . In this context, several transcriptomics studies have been conducted using whole blood, PBMCs and fibroblasts of well-characterized PID patients, to assess the underlying immunological phenotypes at the molecular and cellular levels in more detail (table 1) and in many cases, to further validate the causal relationship between the underlying genotypes and clinical phenotypes.
Notable are several seminal studies of PID patients with susceptibility to a very narrow range of pathogens, such as patients with MYD88 or IRAK4 deficiency who are primarily susceptible to pyrogenic bacterial infections [13, 14] , patients with TBK1, TRIF or TLR3 deficiency [15] [16] [17] which underlies herpes simplex encephalitis of childhood, or a recent study of a child with IRF7 deficiency who was primarily susceptible to severe influenza but otherwise immunocompetent with regard to other common infectious diseases [18] . Such studies have highlighted that often, the underlying gene defect may only affect a narrow repertoire of transcriptional responses while the affected individual's cells remain highly responsive to specific stimulation through alternate receptors, pathways and signaling networks and in particular to ex vivo stimulation with whole organisms, reflecting the high degree of human gene redundancy in host defenses [6] .
Here, we compiled a curated collection of 19 transcriptome datasets, retrieved from the NCBI's Gene Expression Omnibus (GEO) database, to provide as resource for the investigation on inborn errors of immunity. The datasets were loaded into a custom interactive web application, the Gene Expression Browser (GXB), (http://pid.gxbsidra.org/dm3/geneBrowser/list), which allows seamless access to the data and interactive visualization of the transcriptional responses, along with demographic and clinical information [19] . The user can customize data plots by adding multiple layers of parameters (e.g. age, gender, sample type and type of genetic defects), select and modify the sample ordering and gene rank lists, and generate links (mini URL) that can be shared via e-mail or used in publications. The GXB tool enables browsing of a single transcript across multiple studies and datasets, providing new perspectives on the role of a given molecule across biological systems and PID patients. In summary, this dataset collection can aid clinicians and researchers to study and quickly visualize the functional consequences of a variety of well characterized, naturally occurring mutations on a genome-wide scale.
Material and Methods
A total of 157 datasets were identified in GEO using the following search query: Homo sapiens AND ("primary immunodeficiency diseases" OR "primary immunodeficiencies diseases" OR PID OR "autosomal recessive" OR "autosomal dominant" OR "inherited deficiency") AND ("Expression profiling by array"). All GEO entries that were returned with this query were manually curated. This process involved reading all the descriptions available for the datasets, the study designs and corresponding research articles.
Finally, a total of 19 datasets were retained because they contained samples which were obtained from well characterized patients with known PIDs (i.e. the genetic etiology had been identified) or the samples were obtained from patients which were considered to have common variable immunodeficiency (CVID). These include datasets that were generated from whole blood, PBMCs, fibroblasts, B cells, iPS and kidney biopsy of individuals with defects in intrinsic and innate immunity, combined immunodeficiencies with associated or syndromic features, autoinflammatory disorders, congenital defects of phagocyte number, functions, or both, predominantly antibody deficiencies and diseases of immune dysregulation. The selected datasets are listed in Table 1 . A breakdown of the dataset collection by category in accordance to the most recently published update on PID classification from International Union of Immunological Societies Expert Committee [5, 9] is shown in Figure 1 .
The selected datasets were downloaded from GEO by using the SOFT file format. Then, the datasets were uploaded onto our web tool, called the Gene Expression Browser (GXB), an interactive application hosted on the Amazon Web Services cloud [19] . Information about samples and study design were also uploaded. The available samples were assigned to groups based on the individuals and deficiencies studied and genes were ranked according to different group comparisons allowing the identification of transcripts that were differentially expressed between the patient's and control subject's cells 
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